The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Pseudomonas Aeruginosa Biofilms in Cystic fibrosis
Abstract
The persistence of chronic Pseudomonas aeruginosa lung infections in cystic fibrosis (CF) patients is due to biofilm-growing mucoid (alginate-producing) strains. A biofilm is a structured consortium of bacteria, embedded in a self-produced polymer matrix consisting of polysaccharide, protein and DNA. In CF lungs, the polysaccharide alginate is the major part of the P. aeruginosa biofilm matrix. Bacterial biofilms cause chronic infections because they show increased tolerance to antibiotics and resist phagocytosis, as well as other components of the innate and the adaptive immune system. As a consequence, a pronounced antibody response develops, leading to immune complex-mediated chronic inflammation, dominated by polymorphonuclear leukocytes. The chronic inflammation is the major cause of the lung tissue damage in CF. Biofilm growth in CF lungs is associated with an increased frequency of mutations, slow growth and adaptation of the bacteria to the conditions in the lungs, and to antibiotic therapy. Low bacterial metabolic activity and increase of doubling times of the bacterial cells in CF lungs are responsible for some of the tolerance to antibiotics. Conventional resistance mechanisms, such as chromosomal β-lactamase, upregulated efflux pumps, and mutations of antibiotic target molecules in the bacteria, also contribute to the survival of P. aeruginosa biofilms. Biofilms can be prevented by early aggressive antibiotic prophylaxis or therapy, and they can be treated by chronic suppressive therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
Stover, C. K., Pham, X. Q., Erwin, A. L., Mizoguchi, S. D., Warrener, P., Hickey, M. J., Brinkman, F. S. L., Hufnagle, W. O., Kowalik, D. J., Lagrou, M., et al. (2000) · Nature · doi:10.1038/35023079 · Cited by 4,573
Antibiotic resistance of bacterial biofilms
Høiby, N., Bjarnsholt, T., Givskov, M., Molin, S., & Ciofu, O. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.011 · Cited by 3,225
Self-citationHigh Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection
Oliver, A., Cantón, R., Campo, P., Baquero, F., & Blázquez, J. (2000) · Science · doi:10.1126/science.288.5469.1251 · Cited by 1,465
Adaptive radiation in a heterogeneous environment
Rainey, P. B., & Travisano, M. (1998) · Nature · doi:10.1038/27900 · Cited by 1,306
Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis
Ramsey, B. W., Pepe, M. S., Quan, J. M., Otto, K. L., Montgomery, A. B., Williams-Warren, J., Vasiljev-K, M., Borowitz, D., Bowman, C. M., Marshall, B. C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400104 · Cited by 1,300
Persister cells and tolerance to antimicrobials
Keren, I., Kaldalu, N., Spoering, A., Wang, Y., & Lewis, K. (2004) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00856-5 · Cited by 1,098
Worlitzsch, D., Tarran, R., Ulrich, M., Schwab, U., Cekici, A., Meyer, K. C., Birrer, P., Bellon, G., Berger, J., Weiss, T., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213870 · Cited by 932
Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients
Bjarnsholt, T., Jensen, P. Ø., Fiandaca, M. J., Pedersen, J., Hansen, C. R., Andersen, C. B., Pressler, T., Givskov, M., & Høiby, N. (2009) · Pediatric Pulmonology · doi:10.1002/ppul.21011 · Cited by 795
Self-citationNew concepts of the pathogenesis of cystic fibrosis lung disease
Boucher, R. C. (2004) · European Respiratory Journal · doi:10.1183/09031936.03.00057003 · Cited by 640
Screening for Quorum-Sensing Inhibitors (QSI) by Use of a Novel Genetic System, the QSI Selector
Rasmussen, T. B., Bjarnsholt, T., Skindersoe, M. E., Hentzer, M., Kristoffersen, P., Köte, M., Nielsen, J., Eberl, L., & Givskov, M. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.5.1799-1814.2005 · Cited by 622
Self-citationAntibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus
Döring, G., Conway, S. P., Heijerman, H. G. M., Hodson, M. E., Høiby, N., Smyth, A., Touw, D. J., & the Consensus Committee, F. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.16d30.x · Cited by 620
Self-citationRole of oxidants in microbial pathophysiology
Miller, R. A., & Britigan, B. E. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.1.1 · Cited by 577
Bjarnsholt, T., Jensen, P. Ø., Burmølle, M., Hentzer, M., Haagensen, J. A. J., Hougen, H. P., Calum, H., Madsen, K. G., Moser, C., Molin, S., et al. (2005) · Microbiology · doi:10.1099/mic.0.27463-0 · Cited by 500
Self-citationPamp, S. J., Gjermansen, M., Johansen, H. K., & Tolker‐Nielsen, T. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06152.x · Cited by 486
Mathee, K., Ciofu, O., Sternberg, C., Lindum, P. W., Campbell, J. I. A., Jensen, P., Johnsen, A. H., Givskov, M., Ohman, D. E., Søren, M., et al. (1999) · Microbiology · doi:10.1099/13500872-145-6-1349 · Cited by 484
Self-citationOxygen Limitation Contributes to Antibiotic Tolerance of Pseudomonas aeruginosa in Biofilms
Borriello, G., Werner, E., Roe, F., Kim, A. M., Ehrlich, G. D., & Stewart, P. S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2659-2664.2004 · Cited by 476
Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment
Valerius, N. H., Koch, C., & Høiby, N. (1991) · The Lancet · doi:10.1016/0140-6736(91)91446-2 · Cited by 475
Self-citationLower Airway Inflammation in Infants and Young Children with Cystic Fibrosis
ARMSTRONG, D. S., GRIMWOOD, K., CARLIN, J. B., CARZINO, R., GUTIÈRREZ, J. P., HULL, J., OLINSKY, A., PHELAN, E. M., ROBERTSON, C. F., & PHELAN, P. D. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.4.96-11058 · Cited by 467
Bjarnsholt, T., Jensen, P. Ø., Rasmussen, T. B., Christophersen, L., Calum, H., Hentzer, M., Hougen, H.-P., Rygaard, J., Moser, C., Eberl, L., et al. (2005) · Microbiology · doi:10.1099/mic.0.27955-0 · Cited by 440
Self-citationMoskowitz, S. M., Ernst, R. K., & Miller, S. I. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.2.575-579.2004 · Cited by 418
Jensen, P. Ø., Bjarnsholt, T., Phipps, R., Rasmussen, T. B., Calum, H., Christoffersen, L., Moser, C., Williams, P., Pressler, T., Givskov, M., et al. (2007) · Microbiology · doi:10.1099/mic.0.2006/003863-0 · Cited by 404
Self-citationAzithromycin Inhibits Quorum Sensing in Pseudomonas aeruginosa
Tateda, K., Comte, R., Péchère, J.-C., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1930-1933.2001 · Cited by 401
Moskowitz, S. M., Foster, J. M., Emerson, J., & Burns, J. L. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.5.1915-1922.2004 · Cited by 397
Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy
Anwar, H., Strap, J. L., & Costerton, J. W. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.7.1347 · Cited by 383
Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis
Armstrong, D. S., Grimwood, K., Carzino, R., Carlin, J. B., Olinsky, A., & Phelan, P. D. (1995) · BMJ · doi:10.1136/bmj.310.6994.1571 · Cited by 357
and the in vitroand in vivo biofilm mode of growth
Høiby, N., Krogh Johansen, H., Moser, C., Song, Z., Ciofu, O., & Kharazmi, A. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(00)01349-6 · Cited by 356
Self-citationNeutrophil Recruitment to the Lungs during Bacterial Pneumonia
Craig, A., Mai, J., Cai, S., & Jeyaseelan, S. (2009) · Infection and Immunity · doi:10.1128/iai.00832-08 · Cited by 349
Bagge, N., Schuster, M., Hentzer, M., Ciofu, O., Givskov, M., Greenberg, E. P., & Høiby, N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1175-1187.2004 · Cited by 345
Self-citationThe causes of Pseudomonas diversity
Spiers, A. J., Buckling, A., & Rainey, P. B. (2000) · Microbiology · doi:10.1099/00221287-146-10-2345 · Cited by 344
Significant Microbiological Effect of Inhaled Tobramycin in Young Children with Cystic Fibrosis
Gibson, R. L., Emerson, J., McNamara, S., Burns, J. L., Rosenfeld, M., Yunker, A., Hamblett, N., Accurso, F., Dovey, M., Hiatt, P., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-855oc · Cited by 318
Jensen, T., Pedersen, S. S., Garne, S., Heilmann, C., Høiby, N., & Koch, C. (1987) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/19.6.831 · Cited by 314
Self-citationHassett, D. J., Cuppoletti, J., Trapnell, B., Lymar, S. V., Rowe, J. J., Sun Yoon, S., Hilliard, G. M., Parvatiyar, K., Kamani, M. C., Wozniak, D. J., et al. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00152-7 · Cited by 313
Maciá, M. D., Blanquer, D., Togores, B., Sauleda, J., Pérez, J. L., & Oliver, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3382-3386.2005 · Cited by 309
Smith, A. L., Fiel, S. B., Mayer-Hamblett, N., Ramsey, B., & Burns, J. L. (2003) · Chest · doi:10.1378/chest.123.5.1495 · Cited by 307
Early intervention and prevention of lung disease in cystic fibrosis: a European consensus
Döring, G., & Hoiby, N. (2004) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2004.03.008 · Cited by 304
Pharmacokinetics and Bioavailability of Aerosolized Tobramycin in Cystic Fibrosis
Geller, D. E., Pitlick, W. H., Nardella, P. A., Tracewell, W. G., & Ramsey, B. W. (2002) · Chest · doi:10.1378/chest.122.1.219 · Cited by 300
Burns, J. L., Van Dalfsen, J. M., Shawar, R. M., Otto, K. L., Garber, R. L., Quan, J. M., Montgomery, A. B., Albers, G. M., Ramsey, B. W., & Smith, A. L. (1999) · The Journal of Infectious Diseases · doi:10.1086/314727 · Cited by 289
Oliver, A., Baquero, F., & Blázquez, J. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02855.x · Cited by 267
Hoffmann, N., Lee, B., Hentzer, M., Rasmussen, T. B., Song, Z., Johansen, H. K., Givskov, M., & Høiby, N. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01011-06 · Cited by 267
Self-citationEradication of early Pseudomonas aeruginosa infection
Høiby, N., Frederiksen, B., & Pressler, T. (2005) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2005.05.018 · Cited by 255
Self-citationCiofu, O., Riis, B., Pressler, T., Poulsen, H. E., & Høiby, N. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2276-2282.2005 · Cited by 251
Self-citationWestbrock-Wadman, S., Sherman, D. R., Hickey, M. J., Coulter, S. N., Zhu, Y. Q., Warrener, P., Nguyen, L. Y., Shawar, R. M., Folger, K. R., & Stover, C. K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2975 · Cited by 242
Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis.
Pedersen, S. S., Hoiby, N., Espersen, F., & Koch, C. (1992) · Thorax · doi:10.1136/thx.47.1.6 · Cited by 240
Small-Colony Variants of Pseudomonas aeruginosa in Cystic Fibrosis
Rohde, M. (1999) · Clinical Infectious Diseases · doi:10.1086/598644 · Cited by 238
Jalal, S., Ciofu, O., Høiby, N., Gotoh, N., & Wretlind, B. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.710-712.2000 · Cited by 236
Self-citationIncreased mutability of Pseudomonas aeruginosa in biofilms
Driffield, K., Miller, K., Bostock, J. M., O'Neill, A. J., & Chopra, I. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn044 · Cited by 234
SZAFF, M., HØIBY, N., & FLENSBORG, E. W. (1983) · Acta Paediatrica · doi:10.1111/j.1651-2227.1983.tb09789.x · Cited by 233
Self-citationYang, L., Haagensen, J. A. J., Jelsbak, L., Johansen, H. K., Sternberg, C., Høiby, N., & Molin, S. (2008) · Journal of Bacteriology · doi:10.1128/jb.01581-07 · Cited by 225
Self-citationHansen, C. R., Pressler, T., & Høiby, N. (2008) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.06.009 · Cited by 214
Self-citationJelsbak, L., Johansen, H. K., Frost, A.-L., Thøgersen, R., Thomsen, L. E., Ciofu, O., Yang, L., Haagensen, J. A. J., Høiby, N., & Molin, S. (2007) · Infection and Immunity · doi:10.1128/iai.01282-06 · Cited by 212
Self-citationPharmacokinetics of inhaled colistin in patients with cystic fibrosis
Ratjen, F., Rietschel, E., Kasel, D., Schwiertz, R., Starke, K., Beier, H., van Koningsbruggen, S., & Grasemann, H. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki461 · Cited by 208
Høiby, N. (1977) · PubMed · Cited by 207
Self-citationCiofu, O., Mandsberg, L. F., Bjarnsholt, T., Wassermann, T., & Høiby, N. (2010) · Microbiology · doi:10.1099/mic.0.033993-0 · Cited by 201
Self-citationGoldstein, W., & Döring, G. (1986) · PubMed · doi:10.1164/arrd.1986.134.1.49 · Cited by 194
Dynamics and Spatial Distribution of β-Lactamase Expression in Pseudomonas aeruginosa Biofilms
Bagge, N., Hentzer, M., Andersen, J. B., Ciofu, O., Givskov, M., & Høiby, N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1168-1174.2004 · Cited by 192
Self-citationKolpen, M., Hansen, C. R., Bjarnsholt, T., Moser, C., Christensen, L. D., van Gennip, M., Ciofu, O., Mandsberg, L., Kharazmi, A., Doring, G., et al. (2010) · Thorax · doi:10.1136/thx.2009.114512 · Cited by 184
Self-citationHaagensen, J. A. J., Klausen, M., Ernst, R. K., Miller, S. I., Folkesson, A., Tolker-Nielsen, T., & Molin, S. (2007) · Journal of Bacteriology · doi:10.1128/jb.00720-06 · Cited by 182
Novel Mouse Model of Chronic Pseudomonas aeruginosa Lung Infection Mimicking Cystic Fibrosis
Hoffmann, N., Rasmussen, T. B., Jensen, P., Stub, C., Hentzer, M., Molin, S., Ciofu, O., Givskov, M., Johansen, H. K., & Høiby, N. (2005) · Infection and Immunity · doi:10.1128/iai.73.4.2504-2514.2005 · Cited by 181
Self-citationDetecting early structural lung damage in cystic fibrosis
Tiddens, H. A. W. M. (2002) · Pediatric Pulmonology · doi:10.1002/ppul.10134 · Cited by 177
Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response
Pedersen, S. S., Kharazmi, A., Espersen, F., & Høiby, N. (1990) · Infection and Immunity · doi:10.1128/iai.58.10.3363-3368.1990 · Cited by 177
Self-citationMoser, C., Kjaergaard, S., Pressler, T., Kharazmi, A., Koch, C., & Høiby, N. (2000) · APMIS · doi:10.1034/j.1600-0463.2000.d01-64.x · Cited by 169
Self-citationLee, B., Haagensen, J. A. J., Ciofu, O., Andersen, J. B., Høiby, N., & Molin, S. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5247-5255.2005 · Cited by 165
Self-citationSaiman, L., Mehar, F., Niu, W. W., Neu, H. C., Shaw, K. J., Miller, G., & Prince, A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.3.532 · Cited by 164
Johansen, H. K., Moskowitz, S. M., Ciofu, O., Pressler, T., & Høiby, N. (2008) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.02.003 · Cited by 161
Self-citationBoucher, J. C., Martinez-Salazar, J., Schurr, M. J., Mudd, M. H., Yu, H., & Deretic, V (1996) · Journal of Bacteriology · doi:10.1128/jb.178.2.511-523.1996 · Cited by 161
Matsui, H., Verghese, M. W., Kesımer, M., Schwab, U. E., Randell, S. H., Sheehan, J. K., Grubb, B. R., & Boucher, R. C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.1090 · Cited by 157
Biofilm formation by the small colony variant phenotype of Pseudomonas aeruginosa
Häußler, S. (2004) · Environmental Microbiology · doi:10.1111/j.1462-2920.2004.00618.x · Cited by 143
Pulmonary oxidative stress response in young children with cystic fibrosis
Hull, J., Vervaart, P., Grimwood, K., & Phelan, P. D. (1997) · Thorax · doi:10.1136/thx.52.6.557 · Cited by 139
Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin
Anwar, H., Strap, J. L., Chen, K., & Costerton, J. W. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.6.1208 · Cited by 132
Bagge, N., Ciofu, O., Hentzer, M., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3406-3411.2002 · Cited by 121
Self-citationParks, Q. M., Young, R. L., Poch, K. R., Malcolm, K. C., Vasil, M. L., & Nick, J. A. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.005728-0 · Cited by 111
Bragonzi, A., Wiehlmann, L., Klockgether, J., Cramer, N., Worlitzsch, D., Döring, G., & Tümmler, B. (2006) · Microbiology · doi:10.1099/mic.0.29175-0 · Cited by 102
Mandsberg, L. F., Ciofu, O., Kirkby, N. S., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00428-08 · Cited by 101
Self-citationMacLeod, D. L., Nelson, L. E., Shawar, R. M., Lin, B. B., Lockwood, L. G., Dirk, J. E., Miller, G. H., Burns, J. L., & Garber, R. L. (2000) · The Journal of Infectious Diseases · doi:10.1086/315312 · Cited by 95
Evaluating the “Leeds criteria” forPseudomonas aeruginosainfection in a cystic fibrosis centre
Proesmans, M., Balińska-Miśkiewicz, W., Dupont, L., Bossuyt, X., Verhaegen, J., Høiby, N., & Boeck, K. D. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00100805 · Cited by 94
Self-citationCiofu, O., Lee, B., Johannesson, M., Hermansen, N. O., Meyer, P., & Høiby, N. (2008) · Microbiology · doi:10.1099/mic.0.2007/010421-0 · Cited by 91
Self-citationCiofu, O., Fussing, V., Bagge, N., Koch, C., & Høiby, N. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.3.391 · Cited by 88
Self-citationPressler, T., Frederiksen, B., Skov, M., Garred, P., Koch, C., & Høiby, N. (2006) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2005.11.002 · Cited by 82
Self-citationSong, Z., Wu, H. W., Ciofu, O., et al. (2003) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05122-0 · Cited by 78
Self-citationDibdin, G. H., Assinder, S. J., Nichols, W. W., & Lambert, P. A. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.5.757 · Cited by 75
Brandt, T., Breitenstein, S., von der Hardt, H., & Tümmler, B. (1995) · Thorax · doi:10.1136/thx.50.8.880 · Cited by 75
Macia, M. D., Borrell, N., Pérez, J. L., & Oliver, A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2665-2672.2004 · Cited by 67
Bagge, N., Ciofu, O., Skovgaard, L. T., & Høiby, N. (2000) · Apmis · doi:10.1034/j.1600-0463.2000.d01-102.x · Cited by 65
Self-citationPedersen, S. S., Espersen, F., Høiby, N., & Jensen, T. G. (1990) · Journal of Clinical Microbiology · doi:10.1128/jcm.28.4.747-755.1990 · Cited by 62
Self-citationMedium term treatment of stable stage cystic fibrosis with recombinant human DNase I.
Shah, P. L., Scott, S. F., Fuchs, H. J., Geddes, D. M., & Hodson, M. E. (1995) · Thorax · doi:10.1136/thx.50.4.333 · Cited by 55
Permin, H., Koch, C., Heiby, N., et al. (1983) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/12.suppl_a.313 · Cited by 53
Inducible nitric oxide synthase (NOS II) is constitutive in human neutrophils
Cedergren, J., Follin, P., Forslund, T., Lindmark, M., Sundqvist, T., & Skogh, T. (2003) · Apmis · doi:10.1034/j.1600-0463.2003.1111008.x · Cited by 53
Wyckoff, T. J. O., Thomas, B., Hassett, D. J., & Wozniak, D. J. (2002) · Microbiology · doi:10.1099/00221287-148-11-3423 · Cited by 50
Moser, C. E., van Gennip, M., Bjarnsholt, T., Jensen, P. Ø., Lee, B., Hougen, H. P., Calum, H., Ciofu, O., Givskov, M., Molin, S., et al. (2009) · Apmis · doi:10.1111/j.1600-0463.2008.00018.x · Cited by 49
Self-citationCiofu, O., Bagge, N., & Høiby, N. (2002) · Apmis · doi:10.1034/j.1600-0463.2002.1101207.x · Cited by 36
Self-citationJohansen, H. K. (1996) · Apmis · doi:10.1111/j.1600-0463.1996.tb05581.x · Cited by 25
Cited by
Bacterial Biofilm and its Role in the Pathogenesis of Disease
Vestby, L. K., Grønseth, T., Simm, R., & Nesse, L. L. (2020) · Antibiotics · doi:10.3390/antibiotics9020059 · Cited by 1,105
Sharma, S., Mohler, J., Mahajan, S. D., Schwartz, S. A., Bruggemann, L., & Aalinkeel, R. (2023) · Microorganisms · doi:10.3390/microorganisms11061614 · Cited by 993
Strategies for combating bacterial biofilm infections
Wu, H., Moser, C., Wang, H.-Z., Høiby, N., & Song, Z.-J. (2015) · International Journal of Oral Science · doi:10.1038/ijos.2014.65 · Cited by 925
Self-citationThe clinical impact of bacterial biofilms
Høiby, N., Ciofu, O., Johansen, H. K., Song, Z., Moser, C., Jensen, P. Ø., Molin, S., Givskov, M., Tolker‐Nielsen, T., & Bjarnsholt, T. (2011) · International Journal of Oral Science · doi:10.4248/ijos11026 · Cited by 894
Self-citationBiofilm infections, their resilience to therapy and innovative treatment strategies
Römling, U., & Balsalobre, C. (2012) · Journal of Internal Medicine · doi:10.1111/joim.12004 · Cited by 865
Metadata
- Authors
- H⊘iby, N., Ciofu, O., & Bjarnsholt, T.
- Venue
- Future Microbiology
- Publisher
- Informa UK Limited
- Published
- 2010-11
- Volume
- 5
- Issue
- 11
- Pages
- 1663-1674
- ISSN
- 1746-0913 (ISSN-L)
- 1746-0921
- OpenAlex
- W2149908911
- Cited by
- 666
- References
- 91
- FWCI
- 8.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.